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Abstract Activation of plasminogen (plg) to plasmin by the
staphylococcal activator, staphylokinase (SAK), is effectively
regulated by the circulating inhibitor, K2-antiplasmin (K2AP).
Here it is demonstrated that intact Staphylococcus aureus cells
and solubilized staphylococcal cell wall proteins not only
protected SAK-promoted plg activation against the inhibitory
effect of K2AP but also enhanced the activation. The findings
suggest that the surface-associated plg activation by SAK
may have an important physiological function in helping
staphylococci in tissue dissemination. Amino acid sequencing
of tryptic peptides originating from the 59-, 56- and 43-kDa
proteins, isolated as putative plg-binding proteins, identified
them as staphylococcal inosine 5P-monophosphate dehydrogen-
ase, K-enolase, and ribonucleotide reductase subunit 2,
respectively. ß 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
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1. Introduction
In order to invade host tissues, bacteria can utilize the plas-
minogen (plg)/plasmin system of the host by employing vari-
ous mechanisms at various stages during infection. These in-
clude the synthesis and secretion of bacterial plg activators
(PA) as well as stimulation of the host cells to secrete PAs
and their inhibitors. Several invasive pathogens express plg-
binding proteins or receptors which immobilize plg on the
bacterial surface and enhance its activation by mammalian
PAs. In essence, these receptors turn the bacteria into proteo-
lytic organisms capable of degrading and invading extracellu-
lar matrix and basement membranes (for reviews see [1,2]).
The staphylococcal PA staphylokinase (SAK) is a 136-amino
acid protein, secreted by certain transduced Staphylococcus
aureus strains (see for review [3]). Based on deduced amino
acid sequences, there are so far four natural SAK variants
di¡ering from each other in only four amino acid residues
[4^7]. Similar to streptokinase (SK), the streptococcal PA
SAK lacks proteolytic activity but can activate plg in a mech-
anism resembling the activation by SK. The initial step of
activation involves complex formation between SAK and
the tiny amount of plasmin formed by a spontaneous conver-
sion of plg to plasmin. The primary formation of the SAK^
plasmin complex is e⁄ciently inhibited by K2-antiplasmin
(K2AP), the main plasmin inhibitor in circulation. The situa-
tion changes drastically when plg or SAK^plasmin complex is
bound to ¢brin, or to another target, through the lysine-bind-
ing sites of plg/plasmin. Most probably occupation of the sites
prevents binding of K2AP to the complex and leads to pro-
tected plasmin activity. Okada et al. [7] have shown that bind-
ing of plg to ¢brinogen fragments enhances the SAK-medi-
ated plg activation. The observation that SAK activates
primarily plg bound to ¢brin clots has created great enthusi-
asm about the role of SAK in thrombolytic therapy [3].
In the present work we have investigated the e¡ect of intact
S. aureus cells as well as of solubilized staphylococcal cell wall
proteins on SAK-induced plg activation. Additionally we have
puri¢ed plg-binding staphylococcal cell wall proteins using
a⁄nity chromatography on immobilized plg and identi¢ed
them by amino acid sequencing.
2. Materials and methods
2.1. Chemicals
K2AP, aprotinin, ethylmaleimide, phenylmethylsulfonyl £uoride,
DNase I, RNase A, and 1,3,4,6-tetrachloro-3K,6K-diphenylglycoluric
acid (Iodogen) were purchased from Sigma and O-aminocaproic acid
(EACA), formic acid and acetonitrile were from Fluka Chemie AG.
Lysostaphin was obtained from Ambi, New York, USA, chromogenic
substrate S-2251 (H-D-valyl-L-leucyl-L-lysine-p-nitroanilide hydro-
chloride) from Chromogenix (formerly KabiVitrum) and sequenc-
ing-grade trypsin form Promega (Madison, WI, USA). Glu-plg was
isolated from citrated outdated human plasma (Finnish Red Cross
Blood Transfusion Center, Helsinki, Finland) using a⁄nity chroma-
tography on immobilized lysine as described [8]. SAK was a gift from
the Medicine Department of Yakult Honsha, Tokyo, Japan.
2.2. Bacterial strains and cultivation
S. aureus strains included in studies were clinical isolates (Labora-
tory of Bacteriology, Division of Clinical Microbiology, HUCH Lab-
oratory Diagnostics, Helsinki University Central Hospital, Helsinki,
Finland) originating from septicemia patients (¢ve strains), from pa-
tients with super¢cial infections (¢ve strains), and one laboratory
strain, strain Newman. Bacteria were maintained on blood agar plates
at 4‡C and transferred every 4^6 weeks. For experiments bacteria
were grown in Todd^Hewitt broth overnight at 37‡C, pelleted by
centrifugation at 2700Ug for 10 min at room temperature, washed
twice with phosphate-bu¡ered saline (PBS) containing 0.02% (w/v)
sodium azide and ¢nally suspended in the same bu¡er containing
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1% (w/v) bovine serum albumin (BSA) as a carrier (PBS^BSA 1%).
Bacterial concentrations were measured spectrophotometrically using
the Klett-OD 80 for 2U108 bacterial cells/ml and kept in an ice bath
to be used within 24 h.
Phenotypic SAK producer status of staphylococcal strains was re-
corded by incubating Glu-plg, spent culture medium from overnight
cultures, and S-2251 at 37‡C and monitoring the cleavage of the
chromogenic substrate spectrophotometrically at 405 nm (Ultrospec
II1, LKB/Wallac).
2.3. Binding of Glu-plg to S. aureus
For binding experiments, Glu-plg was labelled with carrier-free
Na125I (speci¢c activity 100 mCi/ml; Amersham) with the Iodogen
method as described [9,10]. Binding was determined by incubating
2U109 bacteria with 10 ng of [125I]Glu-plg in 500 Wl of PBS^BSA
1% at room temperature for 2 h under continuous mixing. Subse-
quently, the bacterial cells were pelleted and washed twice with 1.0
ml of PBS^BSA 1% and radioactivity associated with bacteria was
quanti¢ed with an 1270 Rackgamma II1 Q-counter (LKB/Wallac).
Speci¢city of binding was determined using 1000-fold molar excess
of unlabeled Glu-plg to inhibit the binding of [125I]Glu-plg.
2.4. Isolation of S. aureus cell wall proteins interacting with Glu-plg
For isolation of staphylococcal surface proteins, S. aureus strain
Newman was treated with lysostaphin as described [11]. For the pu-
ri¢cation, 60 mg of Glu-plg was coupled to Sepharose beads (Phar-
macia) according to the manufacturer’s instructions. Proteins interact-
ing with plg were isolated by passing 120 mg of lysostaphin digest
through a plg^Sepharose column (10 ml) at 4‡C, by washing the
column with 200 ml of PBS and by ¢nally eluting the bound proteins
with 0.2 M EACA in PBS. In order to inactivate possible trace
amounts of plasmin originating from the Sepharose^plg, 100 Wl of
aprotinin, 0.24 TIU/ml, was mixed with the lysostaphin digest prior
to adding to the column. Aprotinin was removed from fractions by
gel ¢ltration on PD-10 columns (Pharmacia) before use in further
experiments. Protein concentrations in various fractions were deter-
mined according to Lowry [12].
2.5. Enhancement of SAK-induced plg activation by S. aureus cells or
by solubilized cell wall proteins
Generation of plasmin activity was monitored by incubating Glu-
plg (2^4 Wg), SAK (10 ng), K2AP (0.1^5 Wg) and S-2251 (58 Wg) in the
presence of various concentrations of intact bacteria in 500 Wl of PBS
containing 0.02^0.16% (w/v) BSA. Alternatively, solubilized S. aureus
cell wall proteins, proteins adsorbed or puri¢ed by a⁄nity chroma-
tography on Sepharose^plg were used instead of intact bacteria. After
incubation for 90^100 min at room temperature bacteria were pelleted
by centrifugation and formation of p-nitroanilide in supernatants was
measured spectrophotometrically at 405 nm.
2.6. Activation of S. aureus-bound and soluble plg by SAK
In order to compare the e⁄ciency of SAK to activate soluble and
receptor-bound plg, a stock solution was prepared by mixing
[125I]Glu-plg (5 Wg/ml) with unlabelled Glu-plg (100 Wg/ml) giving a
speci¢c activity of 72 000 cpm/Wg protein. The amount of Glu-plg
bound to bacteria was then determined by incubating 9.1 Wg of
[125I]plg stock with 2U109 S. aureus cells, either strain Newman or
strain 274, in 500 Wl of PBS^BSA 1% for 2 h at room temperature
under continuous shaking. Subsequently, cells were washed twice with
1 ml of PBS^BSA 1% and transferred into new tubes for counting the
radioactivity associated with bacteria. Activation was ¢nally per-
formed by incubating equal amounts of bacteria-bound or soluble
plg, as judged by the radioactivity, with SAK in a mass proportion
of 1:200 in the presence of 0.08 WM S-2251. After incubation for
100 min at room temperature bacteria were pelleted by centrifugation
and formation of p-nitroanilide in supernatants was measured as de-
scribed above.
2.7. Ligand blotting of S. aureus surface proteins with plg
In order to identify plg-binding proteins of S. aureus, strain New-
man, lysostaphin digest or proteins eluted from Sepharose^plg a⁄nity
column were ¢rst run on 10% SDS^PAGE under non-reducing con-
ditions, transferred electrophoretically to nitrocellulose membrane
(Amersham, Hybond-C extra) and stained with Ponceau S to visualize
the transferred proteins. Subsequently, the membrane was destained,
saturated with 5% (w/v) defatted milk powder in PBS for 2 h at room
temperature, and treated with Glu-plg at a concentration of 10 Wg/ml
in TEN (0.05 M Tris, 0.025 M EDTA, 0.15 M NaCl, pH 7.5) con-
taining 0.05% (v/v) Tween (TEN-Tween) for 12 h at +4‡C in the
presence or absence of 200 mM EACA. After four washes with
TEN-Tween bu¡er the membrane was incubated in a predetermined
dilution of rabbit anti-human plg (Dako) for 2 h at room temper-
ature, followed by four washes with TEN-Tween and by treatment
with a⁄nity-puri¢ed antibodies to rabbit IgG (Jackson Immunore-
search Laboratories, Westgrove, PA, USA) in TEN-Tween. Finally,
after four washes in TEN-Tween, bound plg was visualized by treat-
ing the membranes with 0.5 WM 3,3P-diaminobenzidine tetrahydro-
chloride dihydrate (Fluka) in PBS containing 0.5% (v/v) H2O2.
2.8. Digestion, separation and amino acid sequencing of the proteins
interacting with plg
The cell wall proteins isolated by the a⁄nity chromatography on
Sepharose^plg were separated by electrophoresis using 12% SDS^
PAGE gels [13] and stained with Coomassie brilliant blue R. The
59-, 56-, 45-, 43-, and 39-kDa protein bands were excised from the
gel, washed, reduced, and digested with sequencing-grade trypsin as
described previously [14]. The resulting peptides were solubilized in
300 Wl of 0.1% formic acid and ¢ltered through a 0.2-Wm ¢lter (Milli-
pore, Bedford, MA, USA). The peptides were separated in a reversed
phase HPLC system using a microscale reversed phase Pepmap col-
umn (RP18, LC packings, 0.3 mmU15 cm) and a short concentrating
column of the same material (0.8 mmU2 mm) preceding the separat-
ing column. The peptides were eluted by a linear gradient of acetoni-
trile (4^40% in 100 min) in 0.07% formic acid using a £ow of 2 Wl/min.
The eluting peptides were detected by an on-line UV detector at
214 nm and collected manually in 25% acetonitrile/0.07% formic
acid. Individual peptides were subjected to N-terminal amino acid
sequencing by an automatic Procise 494A amino acid sequencer (Per-
kin Elmer, Applied Biosystems Division, Foster City, CA, USA) using
Edman chemistry.
3. Results
3.1. Enhancement of SAK-induced plg activation by intact
S. aureus cells
In order to study the e¡ect of S. aureus on SAK-induced
plg activation, increasing numbers of intact bacterial cells
(S. aureus, strain 274) were added into the reaction solution
containing Glu-plg, SAK and K2AP. Under these conditions
the plasmin formation was e¡ectively inhibited by K2AP (see
Fig. 1A, open bars). The presence of bacteria led to a dose-
dependent increase of plasmin activity as judged by cleavage
of a chromogenic substrate, S-2251 (data not shown). The
e¡ect was observed with all tested bacterial strains: addition
of 2U108 S. aureus cells, representing either SAK non-pro-
ducers or SAK producers to the reaction solution enhanced
the formation of plasmin, as compared to the control contain-
ing only Glu-plg and SAK (Fig. 1A). Further, it was tested
whether there was a correlation between the ability of various
S. aureus strains to enhance SAK-induced plg activation and
the plg-binding capacity of the strains. As seen in the inset of
Fig. 1A, the more [125I]Glu-plg the S. aureus strain was able to
bind, the more e¡ective it was in enhancing the SAK-induced
plg activation.
The ability of SAK to activate S. aureus-bound or soluble
plg was studied by incubating SAK with equal amounts of the
two plg forms. As seen in Fig. 1B, at a 1:200 molar ratio SAK
was able to generate detectable plasmin activity only when plg
was bound to S. aureus surface, either strain Newman or
strain 247. The presence of exogenous SAK was important
for the activation since in the absence of SAK no plasmin
was formed from either plg forms.
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3.2. Enhancement of SAK-induced plg activation by S. aureus
cell wall proteins
Similar to the intact S. aureus cells also the solubilized
staphylococcal cell wall protein pool abolished the K2AP-
mediated inhibition of plasmin and enhanced SAK-induced
plg activation in a dose-dependent way at concentrations of
50^100 Wg/ml (Fig. 2). The ability of the cell wall protein pool
to enhance SAK-induced plg activation was abolished when it
was passed through the plg a⁄nity column (Fig. 2). However,
the proteins bound to the column retained the ability to pro-
tect against K2AP-mediated inhibition and to enhance SAK-
induced plg activation; a reaction solution containing 25 Wg/
ml of plg-binding proteins generated plasmin formation cor-
responding to that produced in the presence of 100^200 Wg/ml
of whole lysostaphin digest (Fig. 2).
3.3. Identi¢cation of the plg binding proteins
SDS^PAGE analysis of solubilized S. aureus cell wall pro-
Fig. 1. Enhancement of SAK-induced plg activation by intact S. aureus cells as judged by cleavage of the chromogenic substrate S-2251.
A: Plasmin formation in the presence of various combinations of plg, SAK and K2AP (white bars) and enhancement of plasmin formation
when various SAK-non-producing (hatched bars) and SAK-producing (gray bars) staphylococcal strains were incubated together with plg, SAK
and K2AP. Inset: Correlation of plg-binding capacity and enhancement of SAK-induced plg activation by various S. aureus strains. Plg activa-
tion is indicated as optical density at 405 nm after cleavage of chromogenic substrate S-2251, and relative plg binding as percentages of binding
of [125I]Glu-plg to S. aureus, strain Newman, which is expressed as 100%. B: SAK-induced activation of free soluble plg (gray bars) and plg
bound to plg-binding structures (hatched bars) on S. aureus, strain Newman and strain 274. Presence or absence of SAK in the incubation me-
dium is indicated as + or 3, respectively. For details, see Section 2.
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teins, isolated by a⁄nity chromatography on Sepharose^plg,
revealed major 59-, 56- and 39-kDa proteins as well as minor
45- and 43-kDa protein bands (Fig. 3A). Ligand blotting with
Glu-plg showed that the 59-, 56-, and 43-kDa proteins bound
very e⁄ciently to soluble plg, whereas the 39-, and 45-kDa
proteins showed weaker plg-binding ability (Fig. 3B). In the
presence of 0.2 M EACA ligand blotting with plg showed no
immunoreactive bands (data not shown).
Peptide sequences from the plg-binding proteins were
matched against protein databases [15]. These comparisons
revealed high homologies between the 59-, 56-, and 43-kDa
proteins with inosine 5P-monophosphate dehydrogenase
(IMPDH), K-enolase and ribonucleotide reductase of di¡erent
species, respectively. When the obtained amino acid sequences
were compared with IMPDH (un¢nished genomic sequence:
gn1|TIGR 1280| S. aureus 8087), K-enolase (accession number
T47276), and ribonucleotide reductase L chain (accession
number AJ133495) of S. aureus, all peptides corresponded
to the candidate proteins thus providing a reliable identi¢ca-
tion of the three major plg-binding proteins (Fig. 4). The
quantity of the 45-kDa protein was too low to allow for
identi¢cation, and the sequences originating from the 39-
kDa protein band did not match completely any single pro-
tein, suggesting unsuccessful puri¢cation of the protein using
preparative gel electrophoresis.
4. Discussion
The present study shows that intact S. aureus and plg-bind-
ing components isolated from the staphylococcal cell not only
protected plasmin against the inhibition by K2AP but also
enhanced the SAK-induced plg activation. In addition, iden-
ti¢cation of the three staphylococcal proteins, IMPDH,
K-enolase and ribonucleotide reductase, which were shown
to to bind plg, suggests a role for these proteins as putative
plg-binding structures of S. aureus surface.
Our results are in accordance with the earlier observation
showing that plasmin bound to S. aureus surface is protected
Fig. 2. Enhancement of SAK-induced plg activation by various amounts of lysostaphin released cell wall proteins (strain Newman). Plasmin
formation, as judged by cleavage of the chromogenic substrate S-2251, when indicated concentrations of lysostaphin released cell wall proteins
(hatched bars), proteins passed through the plg a⁄nity column (gray bars) and proteins eluted from the a⁄nity column (black bars) were incu-
bated together with plg, SAK and K2AP (white bar).
Fig. 3. Cell wall proteins of S. aureus interacting with plg. A: Coo-
massie blue staining of SDS^PAGE analysis of cell wall proteins of
S. aureus, strain Newman, released by lysostaphin treatment (Lys-
Dig; 60 Wg) as well as of the pool of cell wall plg-binding proteins
isolated by a⁄nity chromatography on Sepharose^plg (Pool; 2 Wg).
B: Pool of plg-binding proteins diluted 1:3, 1:9 and 1:27 (corre-
sponding approximately to 630 ng, 210 ng and 70 ng of protein, re-
spectively) visualized by ligand blotting employing plg and anti-plg
antibodies. C: Control of ligand blotting without plg. Migrations of
molecular weight markers are indicated on the left. For details, see
Section 2.
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against K2AP [10]. Most probably the cell wall plg-binding
structures occupy the lysine-binding sites of the plg molecule
and thus prevent the interaction of K2AP with active plasmin.
Additionally, Christner and Boyle [16] demonstrated that
plasmin is formed on the surface of SAK-producing S. aureus
cells cultured in plasma milieu containing functional K2AP.
The present study shows that the plasmin formation on the
bacterial surface takes place in an enhanced manner, and that
there is a direct correlation between the capacities of a
S. aureus cell to bind plg and to enhance the SAK-induced
plg activation in the presence of K2AP. These ¢ndings further
emphasize the role of staphylococcal plg-binding proteins in
SAK-induced activation of plg.
Binding of Glu-plg to staphylococcal plg-binding proteins
made it more sensitive to SAK-mediated activation. This was
clearly shown in experiments where the activation of S. aureus-
bound plg by SAK resulted in active plasmin formation,
whereas the same amount of SAK was unable to produce
any measurable plasmin from the same amount of soluble
plg. The enhanced activation e⁄ciency may be due to a con-
formational change in the Glu-plg molecule induced by plg-
binding proteins of S. aureus thus making bacteria-bound plg
Fig. 4. Comparison of sequences of tryptic peptides of plg-binding proteins with sequences of S. aureus proteins. Alignment of peptides (ex-
pressed in bold) originating from the 59-kDa protein with IMPDH (A), peptides from the 56-kDa protein with K-enolase (B), and of peptides
from the 43-kDa protein with ribonucleotide reductase L-chain (C). Accession numbers of the proteins are indicated in parentheses. Numbers
above sequences shown in bold refer to fractions used for sequencing. For details, see Section 2.
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more susceptible to activation by SAK. This type of activation
mechanism has been proposed to other PAs, such as tissue-
type plasminogen activator [10]. These ¢ndings are also in
good agreement with the recent observation showing that
SAK has a higher binding a⁄nity towards plg bound to ¢brin
fragments than towards soluble plg [17], and that SAK in-
duces strong activation of plg bound to ¢brinogen fragments
[7].
Recent evidence indicates that the SAK-induced activation
starts with a complex formation between SAK and a small
amount of plasmin which is probably formed in circulation as
a result of endogenous activation. The active site exposed in
the complex can subsequently convert SAK^plg complexes to
SAK/plasmin and plg to plasmin (for a review, see [3]). In the
present experimental setting, the puri¢ed Glu-plg was pre-
treated with insolubilized aprotinin in order to remove the
possible tiny amount of plasmin. It is, however, not excluded
that on S. aureus cells a proportion of the receptor-bound
Glu-plg might be converted to plasmin and would be subse-
quently responsible for the enhanced plg activation.
Similar to intact bacterial cells, solubilized staphylococcal
cell wall proteins could enhance SAK-induced plg activation
in the presence of K2AP. This e¡ect could be abolished by
adsorption with immobilized plg indicating that at least part
of the plg-binding capacity of S. aureus is mediated by surface
proteins. We were able to purify the proteins responsible for
the enhancement of activation by using an a⁄nity chromatog-
raphy on immobilized Glu-plg. The 59-, 56-, and 43-kDa
proteins, which exhibited strong plg-binding capacity in the
ligand-blotting assay, were identi¢ed as staphylococcal
IMPDH, K-enolase and ribonucleotide reductase, respectively.
All these observations favor the idea that these proteins, as
tentative plg-binding proteins, are also responsible for the
enhanced SAK-induced plg activation.
IMPDH is a key enzyme in purine nucleotide biosynthesis
by catalyzing NAD-dependent conversion of inosine 5P-mono-
phosphate to xanthosine 5P-monophosphate. The importance
of IMPDH in maintaining cellular guanylate pools has made
it a target for a number of immunosuppressive agents (for a
review, see [18]). Another tentative plg-binding molecule, ri-
bonucleotide reductase, belongs to the group of enzymes pro-
viding the only mechanism by which nucleotides can be con-
verted to deoxynucleotides. Both of these enzymes are
intracellular and there is no previous evidence for their extra-
cellular localization. In contrast, K-enolase (2-phospho-D-glyc-
erate hydrolyase), an intracellular key enzyme of the glycolytic
pathway, has been identi¢ed as a plg/plasmin-binding struc-
ture on the surface of several eukaryotic cells [19^21] and on
hemolytic group A streptococci [22].
More recently, Modun and Williams [23] demonstrated that
another intracellular glycolytic enzyme, glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), functions as a transfer-
rin receptor on S. aureus surface. The puri¢ed staphylococcal
GAPDH also bound plg but its role as a staphylococcal plg-
binding protein has not been reported. In the present inves-
tigation we were not able to ¢nd GAPDH among proteins
interacting with plg. This may be due to di¡erences between
various staphylococcal strains, or due to the fact that plg
binding is a characteristic of the puri¢ed enzyme. GAPDH
has been demonstrated, however, as a target for plg and plas-
min on group A streptococci [24] albeit more recent observa-
tions based on mutational analysis have questioned this prop-
erty [25].
The presence of intracellular proteins on the staphylococcal
surface is intriguing albeit di⁄cult to explain. The surface
localization of K-enolase and GAPDH on eukaryotic or pro-
karyotic cells has been convincingly demonstrated [19^22,26],
thus rendering the idea that also other intracellular proteins
may appear on the bacterial surface quite feasible. The present
results must, however, be considered with caution due to the
possibility that during bacterial cultivation or lysostaphin
treatment some staphylococcal cells break and release intra-
cellular enzymes which then could adsorb to bacterial surface
proteins and become solubilized from the surface as com-
plexes with their carrier molecules. If this were the case, the
proteins eluted from the Sepharose^plg column should also
include the cell wall proteins associated with these putative
plg-binding structures. As revealed by SDS^PAGE and li-
gand-blotting analysis this was not the case but rather all
¢ve proteins eluted were also capable of interacting with
plg. Further, no di¡erences could be observed in protein pat-
terns of lysostaphin digests done in the absence or presence of
20% sucrose in order to prevent the break-down of possible
staphylococcal protoplasts.
The present results indicate that staphylococcal plg-binding
structures may have a physiologically important function and
a possible role as staphylococcal virulence factors. Together
with SAK production, they form a mechanism by which a
staphylococcal cell can generate a protected protease on its
surface which subsequently can assist bacterial spreading by
destroying components of extracellular matrix directly, by ac-
tivating matrix metalloproteinases, and by helping bacteria to
penetrate basement membranes [1,27^29]. In this context,
understanding of in vivo regulation of the expression of
both plg-binding molecules and SAK becomes important. Al-
beit the function of K-enolase as plg-binding protein has been
demonstrated for several eukaryotic cells and for group A
streptococcus, further experimental evidence is required on
the localization and roles of IMPDH, K-enolase and ribonu-
cleotide reductase as staphylococcal plg-binding structures.
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